<!DOCTYPE html>
<html lang="en">
<head>
  <meta charset="utf-8">

  <title>NICE Formulary - ERYTHROMYCIN</title>

  <meta name="X-UA-Compatible" content="IE=edge,chrome=1">
  <meta name="viewport" content="width=device-width, initial-scale=1.0, maximum-scale=1.0">
  <meta name="description" content="">
  <meta name="author" content="NICE - The National Institute of Health and Care Excellence">

  <!--[if lt IE 9]>
  <script src="http://mattonfoot.github.io/NICE.UI/scripts/vendor/html5shiv.js"></script>
  <![endif]-->

  <!-- Le styles -->
  <link rel="stylesheet" href="http://mattonfoot.github.io/NICE.UI/styles/ui.css">

  <!-- Fav and touch icons -->
  <link rel="shortcut icon" href="http://cdn.nice.org.uk/V3/Content/nice/favicon.ico">
  <link rel="apple-touch-icon-precomposed" href="http://cdn.nice.org.uk/V3/Content/nice/favicon-152.png">
  <meta name="msapplication-TileColor" content="#fafafb">
  <meta name="msapplication-TileImage" content="http://cdn.nice.org.uk/V3/Content/nice/favicon-144.png">

  <style>
  .tab-content {
    overflow: auto;
  }
  .tab-content > .tab-pane {
    display: none;
  }
  .tab-content > .active {
    display: block;
  }

  header .nav {
    list-style: decimal inside none;
  }
  header .nav > li {
    display: list-item;
  }
  header .nav > li > a {
    display: block;
    margin: 0;
    padding: 0;
    text-decoration: none;
    color: #01769d;
  }
  header .nav > li > a:hover,
  header .nav > li > a:focus,
  header .nav > li.active > a,
  header .nav > li.active > a:hover,
  header .nav > li.active > a:focus {
    outline: 0;
    color: #08455b;
    background: transparent;
    text-decoration: none;
  }
  header .nav > li > a:hover,
  header .nav > li > a:focus {
    text-decoration: underline;
  }

  [outputclass="title"],
  .title {
    font-size: 19px;
    font-size: 1.9rem;
    line-height: 24px;
    line-height: 2.4rem;
  }

  h3, h4, h5, h6, .title, [outputclass="title"] {
    margin-bottom: 0;
  }

  h1+p, h2+p, h3+p, h4+p, h5+p, h6+p, .title+p, [outputclass="title"]+p {
    margin-top: 0;
  }

  .doses {
    padding-left: 0;
    list-style: none;
  }
  .doses .dose {
    padding-left: 24px;
    padding-left: 2.4rem;
    margin-bottom: 6px;
    margin-bottom: .6rem;
  }
  .doses .adult {
    border-left: 7px solid #346e7f;
  }
  .doses .child {
    border-left: 7px solid #82176F;
  }

  /* DITA symbols */

  ph {
    color: #006;
  }

  tm::before {
    font-size: .8em;
    margin-left: -.2em;
    vertical-align: top;
  }
  tm[tmtype="reg"]::before {
    content: "\00ae";
  }
  tm[tmtype="copy"]::before {
    content: "\00a9";
  }
  tm[tmtype="trade"]::before {
    content: "\2122";
  }

  </style>
</head>

<body id="" class="">
  <header>
    <div class="container">
      <ul class="breadcrumb">
        <li><a href="../">Home</a> <span class="divider glyph-chevron-right"></span></li>
        <li class="active"><a href="../drug/">Drugs</a></li>
      </ul>

      <h1>ERYTHROMYCIN</h1>

        <p><a href="../drugClass/PHP34517.html">MACROLIDES</a></p>

      <nav>
        <ul class="nav nav-list">

          <li class="active"><a href="#indicationsAndDoses" data-toggle="tab">Indications and doses</a></li>
          <li><a href="#pregnancy" data-toggle="tab">Pregnancy</a></li>
          <li><a href="#hepaticImpairment" data-toggle="tab">Hepatic impairment</a></li>
          <li><a href="#renalImpairment" data-toggle="tab">Renal impairment</a></li>
          <li><a href="#directionsForAdministration" data-toggle="tab">Administration</a></li>
          <li><a href="#patientAndCarerAdvice" data-toggle="tab">Patient and carer advice</a></li>
          <li><a href="#cautions" data-toggle="tab">Cautions</a></li>
          <li><a href="#unlicensedUse" data-toggle="tab">Unlicensed use</a></li>
          <li><a href="#prescribingAndDispensingInformation" data-toggle="tab">Prescribing and dispensing</a></li>
          <li><a href="#professionSpecificInformation" data-toggle="tab">Profession specific information</a></li>
          <li><a href="#medicinalForms" data-toggle="tab">Medicinal forms</a></li>
        </ul>
      </nav>

      <br/>
    </div>
  </header>

  <div class="container">
    <div class="tab-content">

      <section class="tab-pane active" id="indicationsAndDoses">
        <h2>Indications and doses</h2>

        <section class="indicationAndDoseGroups">
          <section class="indicationAndDoseGroup">
            <h4 class="indications">
                <span class="indication">Susceptible infections in patients with penicillin hypersensitivity (e.g. respiratory-tract infections (including Legionella infection), skin and oral infections, and campylobacter enteritis)</span>,
            </h4>
            <p class="specificity"><span class="route">By intravenous infusion</span></p>
            <ul class="doses">
              <li class="dose adult"><strong>For adults </strong><br/>
                250&#8211;500 mg 4 times a day, total daily dose may alternatively be given in two divided doses, increased to 500&#8211;1000 mg 4 times a day, dose increase may be used in severe infections.</li>
              <li class="dose adult"><strong>For adults </strong><br/>
                6.25 mg/kg every 6 hours, for mild infections when oral treatment not possible. increased to 12.5 mg/kg every 6 hours, dose increase may be used in severe infections.</li>
              <li class="dose child"><strong>For children 1 month&#8211;1 year</strong><br/>
                125 mg 4 times a day, total daily dose may alternatively be given in two divided doses, increased to 250 mg 4 times a day, dose increase may be used in severe infections.</li>
              <li class="dose child"><strong>For children 2&#8211;7 years</strong><br/>
                250 mg 4 times a day, total daily dose may alternatively be given in two divided doses, increased to 500 mg 4 times a day, dose increase may be used in severe infections.</li>
              <li class="dose child"><strong>For children 8&#8211;17 years</strong><br/>
                250&#8211;500 mg 4 times a day, total daily dose may alternatively be given in two divided doses, increased to 500&#8211;1000 mg 4 times a day, dose increase may be used in severe infections.</li>
              <li class="dose child"><strong>For children </strong><br/>
                12.5 mg/kg every 6 hours (max. per dose 1 g).</li>
            </ul>
          </section>
          <section class="indicationAndDoseGroup">
            <h4 class="indications">
                <span class="indication">Lyme disease</span>,
            </h4>
            <p class="specificity"><span class="route">By mouth</span></p>
            <ul class="doses">
              <li class="dose adult"><strong>For adults </strong><br/>
                500 mg 4 times a day for 14&#8211;21 days.</li>
            </ul>
          </section>
          <section class="indicationAndDoseGroup">
            <h4 class="indications">
                <span class="indication">Early syphilis</span>,
            </h4>
            <p class="specificity"><span class="route">By mouth</span></p>
            <ul class="doses">
              <li class="dose adult"><strong>For adults </strong><br/>
                500 mg 4 times a day for 14 days.</li>
            </ul>
          </section>
          <section class="indicationAndDoseGroup">
            <h4 class="indications">
                <span class="indication">Uncomplicated genital chlamydia</span>,
                <span class="indication">Non-gonococcal urethritis</span>,
            </h4>
            <p class="specificity"><span class="route">By mouth</span></p>
            <ul class="doses">
              <li class="dose adult"><strong>For adults </strong><br/>
                500 mg twice daily for 14 days.</li>
            </ul>
          </section>
          <section class="indicationAndDoseGroup">
            <h4 class="indications">
                <span class="indication">Chronic prostatitis</span>,
            </h4>
            <p class="specificity"><span class="route">By intravenous infusion</span></p>
            <ul class="doses">
              <li class="dose adult"><strong>For adults </strong><br/>
                250&#8211;500 mg 4 times a day, total daily dose may alternatively be given in two divided doses, increased to 4 g daily in divided doses, dose increase may be used severe infections.</li>
              <li class="dose adult"><strong>For adults </strong><br/>
                6.25 mg/kg every 6 hours, for mild infections when oral treatment is not possible, increased to 12.5 mg/kg every 6 hours, dose increase may be used in severe infections.</li>
            </ul>
          </section>
          <section class="indicationAndDoseGroup">
            <h4 class="indications">
                <span class="indication">Prevention and treatment of pertussis</span>,
            </h4>
            <p class="specificity"><span class="route">By mouth</span></p>
            <ul class="doses">
              <li class="dose adult"><strong>For adults </strong><br/>
                (consult local protocol).</li>
              <li class="dose child"><strong>For children 1 month&#8211;1 year</strong><br/>
                125 mg 4 times a day, total daily dose may alternatively be given in two divided doses, increased to 250 mg 4 times a day, dose increase may be used in severe infections.</li>
              <li class="dose child"><strong>For children 2&#8211;7 years</strong><br/>
                250 mg 4 times a day, total daily dose may alternatively be given in two divided doses, increased to 500 mg 4 times a day, dose increase may be used in severe infections.</li>
              <li class="dose child"><strong>For children 8&#8211;17 years</strong><br/>
                250&#8211;500 mg 4 times a day, total daily dose may alternatively be given in two divided doses, increased to 500&#8211;1000 mg 4 times a day, dose increase may be used in severe infections.</li>
            </ul>
          </section>
          <section class="indicationAndDoseGroup">
            <h4 class="indications">
                <span class="indication">Prevention of secondary case of diphtheria in non-immune patient</span>,
            </h4>
            <p class="specificity"><span class="route">By mouth</span></p>
            <ul class="doses">
              <li class="dose adult"><strong>For adults </strong><br/>
                500 mg every 6 hours for 7 days, treat for further 10 days if nasopharyngeal swabs positive after first 7 days' treatment.</li>
              <li class="dose child"><strong>For children 1 month&#8211;1 year</strong><br/>
                125 mg every 6 hours for 7 days, treat for further 10 days if nasopharyngeal swabs positive after first 7 days' treatment.</li>
              <li class="dose child"><strong>For children 2&#8211;7 years</strong><br/>
                250 mg every 6 hours for 7 days, treat for further 10 days if nasopharyngeal swabs positive after first 7 days' treatment.</li>
              <li class="dose child"><strong>For children 8&#8211;17 years</strong><br/>
                500 mg every 6 hours for 7 days, treat for further 10 days if nasopharyngeal swabs positive after first 7 days' treatment.</li>
            </ul>
          </section>
          <section class="indicationAndDoseGroup">
            <h4 class="indications">
                <span class="indication">Prevention of secondary case of invasive group A streptococcal infection in penicillin allergic patients</span>,
            </h4>
            <p class="specificity"><span class="route">By mouth</span></p>
            <ul class="doses">
              <li class="dose adult"><strong>For adults </strong><br/>
                250&#8211;500 mg every 6 hours for 10 days.</li>
              <li class="dose child"><strong>For children 1 month&#8211;1 year</strong><br/>
                125 mg every 6 hours for 10 days.</li>
              <li class="dose child"><strong>For children 2&#8211;7 years</strong><br/>
                250 mg every 6 hours for 10 days.</li>
              <li class="dose child"><strong>For children 8&#8211;17 years</strong><br/>
                250&#8211;500 mg every 6 hours for 10 days.</li>
            </ul>
          </section>
          <section class="indicationAndDoseGroup">
            <h4 class="indications">
                <span class="indication">Prevention of pneumococcal infection in asplenia or in patients with sickle-cell disease, and who are penicillin allergic</span>,
            </h4>
            <p class="specificity"><span class="route">By mouth</span></p>
            <ul class="doses">
              <li class="dose adult"><strong>For adults </strong><br/>
                500 mg twice daily, antibiotic prophylaxis is not fully reliable. It may be discontinued in those over 5 years of age with sickle-cell disease who have received pneumococcal immunisation and who do not have a history of severe pneumococcal infection.</li>
              <li class="dose child"><strong>For children 1 month&#8211;1 year</strong><br/>
                125 mg twice daily, antibiotic prophylaxis is not fully reliable.</li>
              <li class="dose child"><strong>For children 2&#8211;7 years</strong><br/>
                125 mg twice daily, antibiotic prophylaxis is not fully reliable. It may be discontinued in those over 5 years of age with sickle-cell disease who have received pneumococcal immunisation and who do not have a history of severe pneumococcal infection.</li>
              <li class="dose child"><strong>For children 8&#8211;17 years</strong><br/>
                500 mg twice daily, antibiotic prophylaxis is not fully reliable. It may be discontinued in those over 5 years of age with sickle-cell disease who have received pneumococcal immunisation and who do not have a history of severe pneumococcal infection.</li>
            </ul>
          </section>
          <section class="indicationAndDoseGroup">
            <h4 class="indications">
                <span class="indication">Prevention of recurrence of rheumatic fever</span>,
            </h4>
            <p class="specificity"><span class="route">By mouth</span></p>
            <ul class="doses">
              <li class="dose child"><strong>For children 1 month&#8211;1 year</strong><br/>
                125 mg twice daily.</li>
              <li class="dose child"><strong>For children 2&#8211;17 years</strong><br/>
                250 mg twice daily.</li>
            </ul>
          </section>
          <section class="indicationAndDoseGroup">
            <h4 class="indications">
                <span class="indication">Rosacea</span>,
            </h4>
            <p class="specificity"><span class="route">By mouth</span></p>
            <ul class="doses">
              <li class="dose adult"><strong>For adults </strong><br/>
                500 mg twice daily courses usually last 6&#8211;12 weeks and are repeated intermittently.</li>
            </ul>
          </section>
          <section class="indicationAndDoseGroup">
            <h4 class="indications">
                <span class="indication">Acne</span>,
            </h4>
            <p class="specificity"><span class="route">By mouth</span></p>
            <ul class="doses">
              <li class="dose adult"><strong>For adults </strong><br/>
                500 mg twice daily.</li>
            </ul>
          </section>
        </section>
        
        
        
        
        
      </section>



      <section class="tab-pane" id="pregnancy">
        <h2>Advice when patient is pregnant</h2>

            <section class="generalInformation">
              <h3 class="specificity">With <ph outputclass="route">systemic</ph> use</h3>
              <p>Not known to be harmful.</p>
            </section>
      </section>

      <section class="tab-pane" id="hepaticImpairment">
        <h2>Advice regarding hepatic impairment</h2>

            <section class="generalInformation">
              <h3 class="specificity">With <ph outputclass="route">systemic</ph> use</h3>
              <p>May cause idiosyncratic hepatotoxicity.</p>
            </section>
      </section>

      <section class="tab-pane" id="renalImpairment">
        <h2>Advice regarding renal impairment</h2>

            <section class="doseAdjustments">
              <h3 class="specificity">With <ph outputclass="route">systemic</ph> use in adults</h3>
              <p>Max. 1.5&#8239;g daily in severe renal impairment (ototoxicity).</p>
            </section>
            <section class="doseAdjustments">
              <h3 class="specificity">With <ph outputclass="route">systemic</ph> use in children</h3>
              <p>Reduce dose in severe renal impairment (ototoxicity).</p>
            </section>
        
      </section>



      <section class="tab-pane" id="directionsForAdministration">
        <h2>Directions for administration</h2>

            <section class="directionsForAdministration">
              <h3 class="specificity">With <ph outputclass="route">intravenous</ph> use in children</h3>
              <p>Dilute reconstituted solution further in glucose 5% (neutralised with Sodium bicarbonate) or sodium chloride 0.9% to a concentration of 1&#8211;5&#8239;mg/mL; give over 20&#8211;60 minutes.</p><p>Concentration of up to 10&#8239;mg/mL may be used in fluid-restriction if administered via a central venous catheter.</p>
            </section>
            <section class="directionsForAdministration">
              <h3 class="specificity">With <ph outputclass="route">intravenous</ph> use in adults</h3>
              <p>For <i>intravenous infusion</i> (as lactobionate), give intermittently <i>in</i> Glucose 5% (neutralised with sodium bicarbonate) <i>or</i> Sodium chloride 0.9%; dissolve initially in water for injections (1&#8239;g in 20&#8239;mL) then dilute to a concentration of 1&#8211;5&#8239;mg/mL; give over 20&#8211;60 minutes.</p>
            </section>
      </section>

      <section class="tab-pane" id="patientAndCarerAdvice">
        <h2>Advice for patients and carers</h2>

            <section class="patientResources">
              <h3 class="specificity">In children</h3>
                <p class="title">Medicines for Children leaflet: Erythromycin for bacterial infections</p>
              <p>
            <xref format="html" href="http://www.medicinesforchildren.org.uk/erythromycin-for-bacterial-infections">www.medicinesforchildren.org.uk/erythromycin-for-bacterial-infections</xref>
            </p>
            </section>
      </section>



      <section class="tab-pane" id="cautions">
        <h2>Cautions regarding administration</h2>

        <ul>
          <li>
              <strong>With systemic use:</strong>
            avoid in <xref format="dita" href="#PHP78608" type="bookmark" namespace="/treatment-summaries/acute-porphyrias">Acute porphyrias</xref>
          </li>
          <li>
              <strong>With systemic use:</strong>
            neonate under 2 weeks (risk of hypertrophic pyloric stenosis) in neonates
          </li>
        </ul>
      </section>



      <section class="tab-pane" id="unlicensedUse">
        <h2>Unlicensed use</h2>

            <section class="unlicensedUse">
              <h3 class="specificity">With <ph outputclass="route">intravenous</ph> use or <ph outputclass="route">oral</ph> use in children</h3>
              <p>Not licensed for use in gastro-intestinal stasis.</p>
            </section>
      </section>

      <section class="tab-pane" id="prescribingAndDispensingInformation">
        <h2>Information regarding prescribing and dispensing</h2>

            <section class="prescribingAndDispensingInformation">
              <h3 class="specificity">With <ph outputclass="route">oral</ph> use</h3>
              <p>Flavours of oral liquid formulations may include banana.</p>
            </section>
      </section>






      <section class="tab-pane" id="professionSpecificInformation">
        <h2>Profession specific information</h2>

          <h3>Dental practitioners</h3>
        
            <section class="dentalPractitionersFormulary">
              <p>Erythromycin tablets e/c may be prescribed.</p><p>Erythromycin ethyl succinate oral suspension may be prescribed.</p><p>Erythromycin stearate tablets may be prescribed.</p><p>Erythromycin ethyl succinate tablets may be prescribed.</p>
            </section>
      </section>



      <section class="tab-pane" id="medicinalForms">
        <h2>Prepared medicinal forms of ERYTHROMYCIN</h2>


            <section class="licensingVariationStatement">
              <p>There can be variation in the licensing of different medicines containing the same drug.</p>
            </section>
        
          <strong>Forms available from special-order manufacturers include: </strong>
            gel,
            ointment,

            <div id="PHP75527"><a href="../medicinalForm/PHP75527.html" data-target="#PHP75527" data-action="load">Tablet</a></div>
            <div id="PHP75541"><a href="../medicinalForm/PHP75541.html" data-target="#PHP75541" data-action="load">Gastro-resistant tablet</a></div>
            <div id="PHP75534"><a href="../medicinalForm/PHP75534.html" data-target="#PHP75534" data-action="load">Gastro-resistant capsule</a></div>
            <div id="PHP75520"><a href="../medicinalForm/PHP75520.html" data-target="#PHP75520" data-action="load">Oral suspension</a></div>
            <div id="PHP75514"><a href="../medicinalForm/PHP75514.html" data-target="#PHP75514" data-action="load">Powder for solution for infusion</a></div>
            <div id="PHP75549"><a href="../medicinalForm/PHP75549.html" data-target="#PHP75549" data-action="load">Liquid</a></div>
      </section>
    </div>
  </div>

  <script src="http://mattonfoot.github.io/NICE.UI/scripts/vendor/jquery.js"></script>
  <script src="http://cdn.nice.org.uk/V3/Scripts/twitter.bootstrap.js"></script>
  <script src="/content/scripts/NICE.RemoteLoad.js"></script>
</html>
